LAI FUNG HOLD (01125): Discussions on potential reduction in shareholding are still ongoing.
The announcement by Lai Fung Holdings (01125) stated that the board of directors has been in discussions with the key related parties of the company, considering selling them.
LAI FUNG HOLD (01125) announces that the board of directors has been in discussions with key individuals connected to the company regarding selling a portion of their respective shareholdings (potential reduction) to restore the company's public shareholding level. As of the date of this announcement, discussions regarding the potential reduction are still ongoing and a legally binding agreement has not been reached.
Related Articles
Jiangsu Hengrui Pharmaceuticals (01276): SHR-4610 injection obtained drug clinical trial approval letter.
NETCOMTECH (08071): Zheng Minggao appointed as executive director.
GUOEN HOLDINGS (08121) issues profit warning, expecting that the company's owners' share of profits for the mid-term will not be less than approximately 300,000 Hong Kong dollars.
Jiangsu Hengrui Pharmaceuticals (01276): SHR-4610 injection obtained drug clinical trial approval letter.
NETCOMTECH (08071): Zheng Minggao appointed as executive director.
GUOEN HOLDINGS (08121) issues profit warning, expecting that the company's owners' share of profits for the mid-term will not be less than approximately 300,000 Hong Kong dollars.
RECOMMEND
Short Positions on Xiaomi (01810.HK) Surge 53% in a Week as Memory Price Spike Weighs on Sentiment
07/11/2025
Privatization Wave in Hong Kong Stocks: Exiting Liquidity Traps to Enable Strategic Transformation
07/11/2025
Over 30 Foreign Firms Attend Roundtable as Ministry of Commerce Signals Multiple Policy Shifts
07/11/2025
